News

Horizon Capital’s EEGF III backs MAKEUP Group – a fast-growing European e-commerce leader in the beauty segment

Horizon Capital, a U.S. private-equity firm investing in high growth export-oriented and domestic companies primarily in Ukraine and the near region, and MAKEUP Group (MAKEUP), a leading European e-commerce player in the beauty segment, have announced that Horizon Capital’s $200 million Emerging Europe Growth Fund III, LP (EEGF III) fund has acquired a significant minority stake in MAKEUP, becoming its largest financial investor. Details of the transaction are not disclosed.

Horizon Capital Backs Purcari Wineries from EEGF III, its Latest $200 Million Fund

Horizon Capital, a leading private equity firm in the region, announced today that its $200 million Emerging Europe Growth Fund III (“EEGF III”) has invested $7.0 million for a 6.8% stake in Purcari Wineries (“Purcari”, the “Company”).

Ukraine House Davos Reaches New Heights in 2020 – its 3rd Year

The press conference of the Ukraine House Davos Organizing Committee (UHOC) was held at the Interfax-Ukraine Press Center today. The press conference focused on the achievements of Ukraine House Davos, held alongside the World Economic Forum’s 50^th Anniversary meeting last week in Davos, Switzerland, in promoting Ukraine’s image globally and attractiveness as an investment destination.

Interview with Lenna Koszarny, Horizon Capital’s Founding Partner and CEO

STADA to Become a Major Pharma Player in Ukraine by Acquiring Biopharma’s Pharmaceutical Prescription and Consumer Health Business

• STADA makes one of the largest financial investments in the Ukrainian pharmaceutical sector to date and one of the biggest business investments in Ukraine recently.
• Biopharma’s pharmaceutical business will become an integral part of STADA’s Ukrainian organization and has strong growth potential in high-quality prescription and consumer healthcare products.
• STADA CEO Peter Goldschmidt: “With this acquisition, we will become an important player in the Ukrainian pharma market with a strong local production footprint.”

Horizon Capital’s EEGF II fully exits Purcari Wineries, generating 3.3x cash-on-cash

Horizon Capital, a leading private equity firm in the region, announced today that its $370 million EEGF II fund has sold the remaining 22.7% stake held in Purcari Wineries PLC (“Purcari”, the “Company”), after successfully listing Purcari on the Bucharest Stock Exchange last year.  EEGF II has realized a 3.3 times blended gross cash-on-cash return on the exit of its holdings in Purcari.

Biopharma has launched a state-of-the-art $75 million plasma fractionation plant in Ukraine

Biopharma, a top-ten pharmaceutical producer in Ukraine specializing in plasma-based, recombinant and other drugs, has officially opened its innovative fractionator in Bila Tserkva (Kyiv region), the only biopharmaceutical plant of its kind in Eastern Europe and the near region. There are no plasma fractionation plants in any neighboring countries – the closest are in Austria, South Africa and China.  This unique plasma fractionation technology enables the plasma component of human blood to be processed to extract life-saving drugs, requires advanced research and development, GMP-certified equipment and facilities, and investments exceeding $75 million.

Dobrobut attracts investment from Horizon Capital’s new fund EEGF III

Horizon Capital, a U.S. private-equity firm investing in high growth companies in Ukraine and the near region, and Dobrobut, the leading private healthcare services provider in Ukraine, have announced that Horizon Capital’s latest $200 million fund, Emerging Europe Growth Fund III, LP (EEGF III) has acquired a minority stake in Dobrobut. Financial details for this transaction have not been disclosed.

Ajax Systems attracts $10 million investment from Horizon Capital’s new fund EEGF III

Horizon Capital, a U.S. private-equity firm investing in high growth export-oriented and domestic companies in Ukraine and the near region, and Ajax Systems, a leading producer of smart security systems in Ukraine, have announced that Horizon Capital’s latest $200 million fund, Emerging Europe Growth Fund III, LP (EEGF III) has acquired a minority stake in the Company for $10 million.

Horizon Capital hits hard cap with $200m for its third Ukraine-focused fund, the largest fund raised for Ukraine in a decade

Horizon Capital, a U.S. private-equity firm investing in high growth and export-driven companies in Ukraine and the near region, has closed its third fund, Emerging Europe Growth Fund III, L.P. (“EEGF III”, the “Fund”), at its $200 million hard cap, far surpassing the $150 million target.  In what marks the largest private equity fund raised for Ukraine in a decade, Horizon’s EEGF III received strong backing from existing and new investors, attracted by the excellent value, fast growth and abundance of opportunities that Ukraine offers. Led by Founding Partners Lenna Koszarny and Jeffrey C. Neal and Senior Partner Denis Tafintsev, Horizon manages over $850 million in assets from investors with a capital base exceeding $350 billion.  Its Ukraine-focused funds have invested over $650 million in 140 companies employing over 46,000 people.